The National Institutes of Health (NIH) intends to award a non-competitive, brand-name contract to Franklin Young International Inc. for the purchase of a BioComp Gradient Maker and Fractionator. This equipment is required to isolate high-quality subcellular samples for prostate and kidney cancer research through sucrose gradient ultracentrifuge techniques. The acquisition will be conducted under simplified acquisition procedures and will not exceed the simplified acquisition threshold of $350,000. This synopsis is not a request for competitive proposals, but interested parties may submit capability statements to demonstrate their ability to fulfill the requirement.